| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 08/07/2002 | CN1362953A Pyrazole compositions useful as inhibitors of ERK |
| 08/07/2002 | CN1362952A 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands |
| 08/07/2002 | CN1362875A Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 08/07/2002 | CN1362194A Nano Golden lock medicine for keeping kidney essence and its preparation |
| 08/07/2002 | CN1362179A Nano eight-ingredient medicine and its preparation |
| 08/07/2002 | CN1362166A Nano four-drug medicine and its preparation |
| 08/07/2002 | CN1362112A Nano menorrhagia treating Gujing medicine and its preparation |
| 08/07/2002 | CN1362110A Nano Gongxuening medicine and its preparation |
| 08/07/2002 | CN1362106A Nano Gengnian'an medicine for treating climacteric syndrome and its preparation |
| 08/07/2002 | CN1362103A Nano meridian passage dredging medicine and its preparation |
| 08/07/2002 | CN1088596C Chinese medicine with immunosuppression function for treating immunosterility (immunoacyesis) |
| 08/06/2002 | US6429313 Growth hormone secretagogues useful for treatment/prevention of osteoporosis |
| 08/06/2002 | US6429223 Modified forms of pharmacologically active agents and uses therefor |
| 08/06/2002 | US6429211 Administering praziquantel to mammals to treat neurological and abortigenical diseases caused by coccidia (such as equine protozoal myeloencephalitis); reduced side effects |
| 08/06/2002 | US6428769 Breathing aerosols to deposit particles of sildenafil citrate on the lungs; noninvasive therapy for sexual disorders; side effect reduction |
| 08/01/2002 | WO2002059373A2 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
| 08/01/2002 | WO2002059286A2 Adenylate cyclases |
| 08/01/2002 | WO2002059139A1 Androgenic 7-substituted 11-halogen steroids |
| 08/01/2002 | WO2002059126A1 Process for the preparation of a pyrazolo[4,3-d]pyrimidine derivative |
| 08/01/2002 | WO2002059124A2 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 08/01/2002 | WO2002059117A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 08/01/2002 | WO2002059113A1 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 08/01/2002 | WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059109A2 Naphthostyril derivatives and their use as inhibitors of cyclin- dependent kinases |
| 08/01/2002 | WO2002059108A1 Melanocortin receptor agonists |
| 08/01/2002 | WO2002059107A1 Substituted piperidines/piperazines as melanocortin receptor agonists |
| 08/01/2002 | WO2002059095A1 Melanocortin receptor agonists |
| 08/01/2002 | WO2002059082A2 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |
| 08/01/2002 | WO2002058723A2 Chemokines as adjuvants of immune response |
| 08/01/2002 | WO2002058706A2 Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy |
| 08/01/2002 | WO2002058704A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 08/01/2002 | WO2002058703A2 The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers |
| 08/01/2002 | WO2002058679A2 Antiangiogenic compounds and an assay for inhibitors of cell invasion |
| 08/01/2002 | WO2002058636A2 Novel cannabimimetic ligands |
| 08/01/2002 | WO2002030461A3 Methods for treating disorders of the female reproductive system |
| 08/01/2002 | WO2002022572A3 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
| 08/01/2002 | WO2002022166A3 Tweak receptor agonists as anti-angiogenic agents |
| 08/01/2002 | WO2002017963A3 Modulators of intermediate conductance calcium-activated potassium (ikca) channel activity for treating sexual dysfunction |
| 08/01/2002 | WO2002012227A3 Indole, azaindole and indazole derivatives having vegf inhibiting activity |
| 08/01/2002 | WO2002008285A3 Il-17 molecules and uses thereof |
| 08/01/2002 | WO2002005794A3 Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel |
| 08/01/2002 | WO2002002137A3 Contraceptive vaccines for pest control |
| 08/01/2002 | WO2001098279A3 Bis-arylsulfones |
| 08/01/2002 | WO2001089536A3 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders |
| 08/01/2002 | WO2001070979A9 Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer |
| 08/01/2002 | WO2001002000A9 Method and composition for affecting reproductive systems |
| 08/01/2002 | WO2000077040A9 Human intracellular signaling molecules |
| 08/01/2002 | US20020103376 Dithiepino[6,5-b]pyridines, and related compositions and methods |
| 08/01/2002 | US20020103259 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 08/01/2002 | US20020103258 Administering to the cow at least one of an ester of methionine, an ester of methionine amide, and an ester of hydroxy analogue of methionine, or salt of atleast one ester to increase milk production |
| 08/01/2002 | US20020103248 Indole derivatives which are agonists of the progesterone receptor and useful for treatment of carcinoma and adenocarcinomas of uterine leiomyomata, endometriosis or polycystic ovary syndorme in a mammal |
| 08/01/2002 | US20020103242 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/01/2002 | US20020103210 Nitrogen-containing heterocyclic compounds, their production and use |
| 08/01/2002 | US20020103198 Acylamino cyclopropane derivatives |
| 08/01/2002 | US20020103177 E.g. 7alpha,11beta-dimethyl-17beta-hydroxyestr-4-en-3-one; controlling male fertility; stereospecific synthesis starting from adrenosterone, and introducing the 7alpha substituent prior to an 11-substituent |
| 08/01/2002 | US20020103151 Methods and compositions for immunomodulation |
| 08/01/2002 | US20020103123 Administering coumpounds such as aromatic alkyl diamine derivatives as Y5 receptor agonist or antagonist to increase or decrease food consumption |
| 08/01/2002 | US20020102707 Nucleotide sequences coding polypeptide for use in the treatment of sexual disorders |
| 08/01/2002 | US20020102649 Human transport protein homologs |
| 08/01/2002 | US20020102585 Prostate growth-associated membrane proteins |
| 08/01/2002 | US20020102535 Nucleic acid molecules and polypeptides for immune modulation |
| 08/01/2002 | US20020102230 Method for inactivating pathogens |
| 08/01/2002 | US20020100854 Furnace mount and method of installation |
| 08/01/2002 | DE10103647A1 Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates A process for preparing a pyrazolo (4,3-d) pyrimidine derivative |
| 08/01/2002 | DE10100911A1 Verfahren zur Hormonersatztherapie und dessen Darreichungsform A method for hormone replacement therapy and its dosage form |
| 08/01/2002 | CA2435884A1 Process for the preparation of a pyrazolo[4,3-d]pyrimidine derivative |
| 08/01/2002 | CA2435876A1 The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers |
| 08/01/2002 | CA2435775A1 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 08/01/2002 | CA2435409A1 Novel cannabimimetic ligands |
| 08/01/2002 | CA2434558A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 08/01/2002 | CA2434320A1 Chemokines as adjuvants of immune response |
| 08/01/2002 | CA2433025A1 Substituted piperidines/piperazines as melanocortin receptor agonists |
| 08/01/2002 | CA2432991A1 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
| 08/01/2002 | CA2432988A1 Melanocortin receptor agonists |
| 08/01/2002 | CA2432985A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 08/01/2002 | CA2432134A1 Adenylate cyclases |
| 08/01/2002 | CA2432122A1 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |
| 08/01/2002 | CA2431996A1 Melanocortin receptor agonists |
| 07/31/2002 | EP1226825A1 Erection insufficiency remedies |
| 07/31/2002 | EP1226822A2 Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same |
| 07/31/2002 | EP1226279A1 Modulation of neuroendocrine differentiation by protein 25.1 |
| 07/31/2002 | EP1226249A2 Follistatin-related protein zfsta4 |
| 07/31/2002 | EP1226242A1 Human cub-domain-containing protein and gene encoding the same |
| 07/31/2002 | EP1226176A1 Production of mammary secretion antibodies in farm animals |
| 07/31/2002 | EP1226169A2 Molecular structure of rhd negative locus |
| 07/31/2002 | EP1226160A2 Novel antiarrhythmic peptides |
| 07/31/2002 | EP1226159A1 Substituted dipeptides having nos inhibiting activity |
| 07/31/2002 | EP1226155A2 18-nor-steroids as selectively active estrogens |
| 07/31/2002 | EP1226150A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 07/31/2002 | EP1226141A1 Heterocyclic substituted pyrazolones |
| 07/31/2002 | EP1226131A2 Isoxazolecarboxamide derivatives |
| 07/31/2002 | EP1226110A1 Bicyclic amino acids as pharmaceutical agents |
| 07/31/2002 | EP1225915A2 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 07/31/2002 | EP1225888A2 Sustained-release formulations for treating cns-mediated disorders |
| 07/31/2002 | EP1225881A1 Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction |
| 07/31/2002 | EP1137414A4 Use of acetylcholinesterase inhibitors on the modulation of the hypothalamic-pituitary-gonadal axis |
| 07/31/2002 | EP0708656B1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 07/31/2002 | CN1361783A Thiazoloderivatives and pharmaceutical compositions containing them |
| 07/31/2002 | CN1361782A Substituted imidazothiazoles as antidepressant agents |